标题 |
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial
|
网址 | |
DOI |
10.1016/s0140-6736(23)02405-4
doi
|
其它 |
期刊:The Lancet 作者:Ana Oaknin; Laurence Gladieff; Jerónimo Martínez-García; Guillermo Villacampa; Munetaka Takekuma; et al 出版日期:2024-01-06 |
求助人 | |
下载 | 暂无链接,等待应助者上传 |